Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
Genentech (POLIVY)
(https://polivy.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE POLIVY® (polatuzumab vedotin-piiq) for certain types of Diffuse Large B-Cell Lymphoma (https://polivy.com)
Title
POLIVY® (polatuzumab vedotin-piiq) for certain types of Diffuse Large B-Cell Lymphoma
Meta
Learn about POLIVY® (polatuzumab vedotin-piiq) plus R-CHP for adults with certain types of newly diagnosed diffuse large B-cell lymphoma (DLBCL). See full safety information.
H1 Plan your path with POLIVY®
H2 Make the most out of your next doctor’s visit
H2 Starting POLIVY
H2 Financial Support
H3 Every step of your first DLBCL treatment matters
H3 Every step of your first DLBCL treatment matters
H3 This site is intended for US Healthcare Professionals
H3 Link to Third Party Site
H4 What does POLIVY® treat?
H5 Important Safety Information and Indication
H5 Possible serious side effects
H5 I am a Healthcare Professional
H5 I am a Patient or Caregiver
NAV_HEADER_REPEATED_BODY Important Safety Information | POLIVY® (polatuzumab vedotin-piiq) (https://polivy.com/newly-diagnosed/rchp/side-effects/important-safety-information.html)
Title
Important Safety Information | POLIVY® (polatuzumab vedotin-piiq)
Meta
Review the side effects and important safety information for POLIVY® (polatuzumab vedotin-piiq) plus R-CHP. See full safety information.
H1 Indication and Important Safety Information
H3 This site is intended for US Healthcare Professionals
H3 Link to Third Party Site
H4 What does POLIVY® treat?
H5 Possible serious side effects
H5 I am a Healthcare Professional
H5 I am a Patient or Caregiver
NAV_HEADER_HEADING_REPEATED_BODY Preparing for Treatment | POLIVY® (polatuzumab vedotin-piiq) (https://polivy.com/newly-diagnosed/rchp/taking-polivy/preparing-for-treatment.html)
Title
Preparing for Treatment | POLIVY® (polatuzumab vedotin-piiq)
Meta
Review tips on how best to prepare for treatment with POLIVY® (polatuzumab vedotin-piiq) plus R-CHP. See full safety information.
H1 Preparing for Treatment
H2 Tests
H2 Pretreatment medicines
H2 Financial and other support resources
H2 Tips to prepare for your treatment
H2 Questions To Ask Your Doctor
H2 Financial Support
H3 What you may expect
H3 This site is intended for US Healthcare Professionals
H3 Link to Third Party Site
H4 What does POLIVY® treat?
H5 POLIVY Infusion Checklist
H5 Important Safety Information and Indication
H5 Possible serious side effects
H5 I am a Healthcare Professional
H5 I am a Patient or Caregiver
NAV_HEADER_REPEATED_BODY Is POLIVY® Right for Me? (https://polivy.com/newly-diagnosed/rchp/about-polivy/is-polivy-right-for-me.html)
Title
Is POLIVY® Right for Me?
Meta
Understand how POLIVY® (polatuzumab vedotin-piiq) plus R-CHP may help treat adults with certain types of newly diagnosed DLBCL. See full safety information.
H1 Is POLIVY® Right for Me?
H2 POLIVY is part of an FDA-approved treatment regimen for adults with certain types of newly diagnosed DLBCL
H2 Questions To Ask Your Doctor
H2 Financial Support
H3 This site is intended for US Healthcare Professionals
H3 Link to Third Party Site
H4 What does POLIVY® treat?
H5 Why have I been prescribed POLIVY plus R-CHP?
H5 What does R-CHP do?
H5 Important Safety Information and Indication
H5 Possible serious side effects
H5 I am a Healthcare Professional
H5 I am a Patient or Caregiver
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://polivy.com) POLIVY® (polatuzumab vedotin-piiq) for certain types of Diffuse Large B-Cell Lymphoma
[H3] Every step of your first DLBCL treatment matters [H1] Plan your path with POLIVY® POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL). Is POLIVY Right for Me? [H3] Every step of your first DLBCL treatment matters [H1] Plan your path with POLIVY® POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL). Is POLIVY Right for Me? [IMG: discussion guide icon] [H2] Make the most out of your next doctor’s visit Use this guide to find a list of questions you can ask when talking to your doctor. Get Your Guide [IMG: iv bag icon] [H2] Starting POLIVY Learn more about what to expect from treatment with POLIVY and how to prepare for it. Learn More [IMG: dollar sign icon] [H2] Financial Support Learn about financial support and other resources* to help you access POLIVY. Get Support *Contact the Genentech Patient Resource Center at 1-877-436-3683 (Monday-Friday, 6am-5pm PST) for answers to your questions and to be connected to the right Genentech patient support service. For adults with moderate to high risk previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL), POLIVY is a prescription medication used in combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP). It is administered by intravenous infusion every 21 days for six cycles. Learn more about preparing for treatment. The serious to fatal side effects of POLIVY treatment include nerve problems in your arms and legs, infusion-related reactions, low blood cell counts, infections, rare and serious brain infections, tumor lysis syndrome, liver problems, and potential harm to your unborn baby. The most common side effects of POLIVY when used as a first treatment in DLBCL with the medicines rituximab product, cyclophosphamide, doxorubicin, and prednisone include nerve problems in arms and legs, nausea, tiredness or lack of energy, diarrhea, constipation, hair loss, redness and sores of the lining of the mouth, lips, throat, and digestive tract. POLIVY may lower your red or white blood cell counts and increase uric acid levels. See important safety information as well as the full prescribing information. [H5] Important Safety Information and Indication Back to Top [H4] What does POLIVY® treat? POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL). POLIVY is a prescription medicine used with other medicines, bendamustine and a rituximab product, to treat DLBCL, NOS, in adults who have progressed after at least 2 prior therapies. [H5] Possible serious side effects Everyone reacts differently to POLIVY therapy, so it’s important to know what the side effects are. Some people who have been treated with POLIVY have experienced serious to fatal side effects. Your doctor may stop or adjust your treatment if any serious side effects occur. Be sure to contact your healthcare team if there are any signs of these side effects. Nerve problems in your arms and legs: This may happen as early as after your first dose and may worsen with every dose. Your doctor will monitor for signs and symptoms, such as changes in your sense of touch, numbness or tingling in your hands or feet, nerve pain, burning sensation, any muscle weakness, or changes to your walking pattern Infusion-related reactions: You may experience fever, chills, rash, breathing problems, low blood pressure, or hives within 24 hours of your infusion Low blood cell counts: Treatment with POLIVY can cause severe low blood cell counts. Your doctor will monitor your blood counts throughout treatment with POLIVY Infections: If you have a fever of 100.4°F (38°C) or higher, chills, cough, or pain during urination, contact your healthcare team. Your doctor may also give you medication before giving you POLIVY, which may prevent some infections, and will monitor your blood counts throughout treatment with POLIVY. Treatment with POLIVY can cause severe low blood cell counts Rare and serious brain infections: Your doctor will monitor closely for signs and symptoms of these types of infections. Contact your doctor if you experience confusion, dizziness or loss of balance, trouble talking or walking, or vision changes Tumor lysis syndrome: Caused by the fast breakdown of cancer cells. Signs include nausea, vomiting, diarrhea, and lack of energy Potential harm to liver: Some signs include tiredness, weight loss, pain in the abdomen, dark urine, and yellowing of your skin or the white part of your eyes. You may be at higher risk if you already had liver problems or you are taking other medication Skin damage at or near the infusion site: POLIVY may leak out of the vein and into the surrounding tissue during the infusion, which can cause skin or tissue damage. Your doctor will closely monitor for signs and symptoms of skin damage during the infusion. Tell your healthcare provider immediately if you see any fluid leaking at or around the infusion site, or if you notice any burning, tingling, pain, discomfort, swelling and redness at the infusion site Side effects seen most often The most common side effects of POLIVY when used as a first treatment in DLBCL with the medicines rituximab product, cyclophosphamide, doxorubicin, and prednisone include Nerve problems in arms and legs Nausea Tiredness or lack of energy Diarrhea Constipation Hair loss Redness and sores of the lining of the mouth, lips, throat, and digestive tract POLIVY may lower your red or white blood cell counts and increase uric acid levels. The most common side effects of POLIVY when used in DLBCL after at least 2 prior therapies with other medicines, bendamustine and a rituximab product, include Low blood cell counts (platelets, red blood cells, white blood cells) Nerve problems in arms and legs Tiredness or lack of energy Diarrhea Nausea Fever Decreased appetite Infections POLIVY may not be for everyone. Talk to your doctor if you are Pregnant or think you are pregnant: Data have shown that POLIVY may harm your unborn baby Planning to become pregnant: Women should avoid getting pregnant while taking POLIVY. Women should use effective contraception during treatment and for 3 months after their last POLIVY treatment. Men taking POLIVY should use effective contraception during treatment and for 5 months after their last POLIVY treatment Breastfeeding: Women should not breastfeed while taking POLIVY and for 2 months after the last dose These may not be all the side effects. Talk to your healthcare provider for more information about the benefits and risks of POLIVY treatment. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the full Prescribing Information for additional Important Safety Information. TOP
7784 chars
SUB-PAGE (https://polivy.com/newly-diagnosed/rchp/side-effects/important-safety-information.html) Important Safety Information | POLIVY® (polatuzumab vedotin-piiq)
[H1] Indication and Important Safety Information [H4] What does POLIVY® treat? POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL). POLIVY is a prescription medicine used with other medicines, bendamustine and a rituximab product, to treat DLBCL, NOS, in adults who have progressed after at least 2 prior therapies. [H5] Possible serious side effects Everyone reacts differently to POLIVY therapy, so it’s important to know what the side effects are. Some people who have been treated with POLIVY have experienced serious to fatal side effects. Your doctor may stop or adjust your treatment if any serious side effects occur. Be sure to contact your healthcare team if there are any signs of these side effects. Nerve problems in your arms and legs: This may happen as early as after your first dose and may worsen with every dose. Your doctor will monitor for signs and symptoms, such as changes in your sense of touch, numbness or tingling in your hands or feet, nerve pain, burning sensation, any muscle weakness, or changes to your walking pattern Infusion-related reactions: You may experience fever, chills, rash, breathing problems, low blood pressure, or hives within 24 hours of your infusion Low blood cell counts: Treatment with POLIVY can cause severe low blood cell counts. Your doctor will monitor your blood counts throughout treatment with POLIVY Infections: If you have a fever of 100.4°F (38°C) or higher, chills, cough, or pain during urination, contact your healthcare team. Your doctor may also give you medication before giving you POLIVY, which may prevent some infections, and will monitor your blood counts throughout treatment with POLIVY. Treatment with POLIVY can cause severe low blood cell counts Rare and serious brain infections: Your doctor will monitor closely for signs and symptoms of these types of infections. Contact your doctor if you experience confusion, dizziness or loss of balance, trouble talking or walking, or vision changes Tumor lysis syndrome: Caused by the fast breakdown of cancer cells. Signs include nausea, vomiting, diarrhea, and lack of energy Potential harm to liver: Some signs include tiredness, weight loss, pain in the abdomen, dark urine, and yellowing of your skin or the white part of your eyes. You may be at higher risk if you already had liver problems or you are taking other medication Skin damage at or near the infusion site: POLIVY may leak out of the vein and into the surrounding tissue during the infusion, which can cause skin or tissue damage. Your doctor will closely monitor for signs and symptoms of skin damage during the infusion. Tell your healthcare provider immediately if you see any fluid leaking at or around the infusion site, or if you notice any burning, tingling, pain, discomfort, swelling and redness at the infusion site Side effects seen most often The most common side effects of POLIVY when used as a first treatment in DLBCL with the medicines rituximab product, cyclophosphamide, doxorubicin, and prednisone include Nerve problems in arms and legs Nausea Tiredness or lack of energy Diarrhea Constipation Hair loss Redness and sores of the lining of the mouth, lips, throat, and digestive tract POLIVY may lower your red or white blood cell counts and increase uric acid levels. The most common side effects of POLIVY when used in DLBCL after at least 2 prior therapies with other medicines, bendamustine and a rituximab product, include Low blood cell counts (platelets, red blood cells, white blood cells) Nerve problems in arms and legs Tiredness or lack of energy Diarrhea Nausea Fever Decreased appetite Infections POLIVY may not be for everyone. Talk to your doctor if you are Pregnant or think you are pregnant: Data have shown that POLIVY may harm your unborn baby Planning to become pregnant: Women should avoid getting pregnant while taking POLIVY. Women should use effective contraception during treatment and for 3 months after their last POLIVY treatment. Men taking POLIVY should use effective contraception during treatment and for 5 months after their last POLIVY treatment Breastfeeding: Women should not breastfeed while taking POLIVY and for 2 months after the last dose These may not be all the side effects. Talk to your healthcare provider for more information about the benefits and risks of POLIVY treatment. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the full Prescribing Information for additional Important Safety Information. NEXT: The POLIVY Study TOP
4974 chars
SUB-PAGE (https://polivy.com/newly-diagnosed/rchp/taking-polivy/preparing-for-treatment.html) Preparing for Treatment | POLIVY® (polatuzumab vedotin-piiq)
[H1] Preparing for Treatment Tips to prepare for your treatment [H3] What you may expect Your healthcare team is your key partner and best source of information throughout your lymphoma treatment journey. Here are some of the activities the team will help you navigate, leading up to the first treatment: [H2] Tests Your healthcare team will order a series of tests to confirm that your body is ready for treatment. The tests may be repeated during treatment to ensure that it is safe to continue. [H2] Pretreatment medicines To help your body prepare for your cancer treatment, you are likely to receive pretreatment medications. [H2] Financial and other support resources Your healthcare team can help you identify financial support options for POLIVY®. They can also identify organizations that may help support you through your journey. If you’re considering or have started treatment with POLIVY and need more information or help understanding coverage or paying for your medicine, Genentech* has programs to help. For more financial support information, please refer to our Financial Assistance Options. *Contact the Genentech Patient Resource Center at 1-877-436-3683 (Monday-Friday, 6am-5pm PST) for answers to your questions and to get connected to the right Genentech patient support service. [H2] Tips to prepare for your treatment POLIVY plus R-CHP treatment cycles may be lengthy, especially the first one. Here are a few tips to help you plan ahead: Eat a light meal before your appointment to help avoid nausea (feeling sick) during or after your treatment. You may also want to bring along a snack in case you get hungry Drink plenty of water to keep hydrated for your appointment Wear comfortable, loose-fitting clothes for easier infusion access. A blanket may help keep you comfortable if the infusion center is chilly Keep yourself occupied with reading material or an audio device. Your care team may also allow you to bring a friend or family member along for support Arrange transport home prior to your appointment, as you may find it difficult to travel on your own Plan to rest after each treatment cycle, as you may be feeling tired [IMG: thin blue brush stroke] [IMG: checklist icon] [H5] POLIVY Infusion Checklist Download the POLIVY Infusion Checklist for the full list of suggested steps to help you prepare for the infusion experience. Download [IMG: thin green paint stroke] [IMG: discussion guide icon] [H2] Questions To Ask Your Doctor The doctor discussion guide provides a set of questions to ask your care team to help make sense of the information related to your diagnosis and treatment. Download Now [IMG: dollar sign icon] [H2] Financial Support Learn about financial support and other resources to help you access POLIVY Get Support NEXT: How POLIVY Is Given [H5] Important Safety Information and Indication Back to Top [H4] What does POLIVY® treat? POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL). POLIVY is a prescription medicine used with other medicines, bendamustine and a rituximab product, to treat DLBCL, NOS, in adults who have progressed after at least 2 prior therapies. [H5] Possible serious side effects Everyone reacts differently to POLIVY therapy, so it’s important to know what the side effects are. Some people who have been treated with POLIVY have experienced serious to fatal side effects. Your doctor may stop or adjust your treatment if any serious side effects occur. Be sure to contact your healthcare team if there are any signs of these side effects. Nerve problems in your arms and legs: This may happen as early as after your first dose and may worsen with every dose. Your doctor will monitor for signs and symptoms, such as changes in your sense of touch, numbness or tingling in your hands or feet, nerve pain, burning sensation, any muscle weakness, or changes to your walking pattern Infusion-related reactions: You may experience fever, chills, rash, breathing problems, low blood pressure, or hives within 24 hours of your infusion Low blood cell counts: Treatment with POLIVY can cause severe low blood cell counts. Your doctor will monitor your blood counts throughout treatment with POLIVY Infections: If you have a fever of 100.4°F (38°C) or higher, chills, cough, or pain during urination, contact your healthcare team. Your doctor may also give you medication before giving you POLIVY, which may prevent some infections, and will monitor your blood counts throughout treatment with POLIVY. Treatment with POLIVY can cause severe low blood cell counts Rare and serious brain infections: Your doctor will monitor closely for signs and symptoms of these types of infections. Contact your doctor if you experience confusion, dizziness or loss of balance, trouble talking or walking, or vision changes Tumor lysis syndrome: Caused by the fast breakdown of cancer cells. Signs include nausea, vomiting, diarrhea, and lack of energy Potential harm to liver: Some signs include tiredness, weight loss, pain in the abdomen, dark urine, and yellowing of your skin or the white part of your eyes. You may be at higher risk if you already had liver problems or you are taking other medication Skin damage at or near the infusion site: POLIVY may leak out of the vein and into the surrounding tissue during the infusion, which can cause skin or tissue damage. Your doctor will closely monitor for signs and symptoms of skin damage during the infusion. Tell your healthcare provider immediately if you see any fluid leaking at or around the infusion site, or if you notice any burning, tingling, pain, discomfort, swelling and redness at the infusion site Side effects seen most often The most common side effects of POLIVY when used as a first treatment in DLBCL with the medicines rituximab product, cyclophosphamide, doxorubicin, and prednisone include Nerve problems in arms and legs Nausea Tiredness or lack of energy Diarrhea Constipation Hair loss Redness and sores of the lining of the mouth, lips, throat, and digestive tract POLIVY may lower your red or white blood cell counts and increase uric acid levels. The most common side effects of POLIVY when used in DLBCL after at least 2 prior therapies with other medicines, bendamustine and a rituximab product, include Low blood cell counts (platelets, red blood cells, white blood cells) Nerve problems in arms and legs Tiredness or lack of energy Diarrhea Nausea Fever Decreased appetite Infections POLIVY may not be for everyone. Talk to your doctor if you are Pregnant or think you are pregnant: Data have shown that POLIVY may harm your unborn baby Planning to become pregnant: Women should avoid getting pregnant while taking POLIVY. Women should use effective contraception during treatment and for 3 months after their last POLIVY treatment. Men taking POLIVY should use effective contraception during treatment and for 5 months after their last POLIVY treatment Breastfeeding: Women should not breastfeed while taking POLIVY and for 2 months after the last dose These may not be all the side effects. Talk to your healthcare provider for more information about the benefits and risks of POLIVY treatment. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the full Prescribing Information for additional Important Safety Information. TOP
7964 chars
SUB-PAGE (https://polivy.com/newly-diagnosed/rchp/about-polivy/is-polivy-right-for-me.html) Is POLIVY® Right for Me?
[H1] Is POLIVY® Right for Me? [H2] POLIVY is part of an FDA-approved treatment regimen for adults with certain types of newly diagnosed DLBCL In addition to POLIVY, this regimen contains 4 other medicines: a rituximab product (R); cyclophosphamide (C); doxorubicin, also known as Adriamycin (H); and prednisone (P). The full treatment regimen is usually referred to as POLIVY plus R-CHP (pronounced “AR-chip”). [H5] Why have I been prescribed POLIVY plus R-CHP? Your care team may recommend POLIVY plus R-CHP as your first DLBCL treatment regimen because they think it is the most appropriate option for you. [H5] What does R-CHP do? R-CHP also helps fight the cancer. These medicines may also affect healthy cells. [IMG: dark green IV bag icon] Rituximab product (R) is an immunotherapy that works differently than POLIVY. It is designed to identify B cells (including cancerous B cells) and either destroys these cells on its own or helps the immune system to destroy them. [IMG: dark green IV bag icon] Cyclophosphamide (C) and doxorubicin (H) are chemotherapy treatments that are designed to kill fast-growing cells in your body, including cancer cells. [IMG: pill icon] Prednisone (P) is a medicine that helps reduce inflammation and lower your body’s immune response. Prednisone is also used alone or with other drugs to prevent or treat certain conditions related to cancer. The full treatment regimen is usually referred to as POLIVY plus R-CHP (pronounced “AR-chip”). [IMG: thin blue brush stroke] [IMG: speech bubble icon] Talk to your healthcare team about possible side effects. Please also see the full Prescribing Information for a complete list of side effects. [IMG: thin green paint stroke] [IMG: discussion guide icon] [H2] Questions To Ask Your Doctor The doctor discussion guide provides a set of questions to ask your care team to help make sense of the information related to your diagnosis and treatment. Learn More [IMG: dollar sign icon] [H2] Financial Support Learn about financial support and other resources to help you access POLIVY Get Support NEXT: Side Effects [H5] Important Safety Information and Indication Back to Top [H4] What does POLIVY® treat? POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL). POLIVY is a prescription medicine used with other medicines, bendamustine and a rituximab product, to treat DLBCL, NOS, in adults who have progressed after at least 2 prior therapies. [H5] Possible serious side effects Everyone reacts differently to POLIVY therapy, so it’s important to know what the side effects are. Some people who have been treated with POLIVY have experienced serious to fatal side effects. Your doctor may stop or adjust your treatment if any serious side effects occur. Be sure to contact your healthcare team if there are any signs of these side effects. Nerve problems in your arms and legs: This may happen as early as after your first dose and may worsen with every dose. Your doctor will monitor for signs and symptoms, such as changes in your sense of touch, numbness or tingling in your hands or feet, nerve pain, burning sensation, any muscle weakness, or changes to your walking pattern Infusion-related reactions: You may experience fever, chills, rash, breathing problems, low blood pressure, or hives within 24 hours of your infusion Low blood cell counts: Treatment with POLIVY can cause severe low blood cell counts. Your doctor will monitor your blood counts throughout treatment with POLIVY Infections: If you have a fever of 100.4°F (38°C) or higher, chills, cough, or pain during urination, contact your healthcare team. Your doctor may also give you medication before giving you POLIVY, which may prevent some infections, and will monitor your blood counts throughout treatment with POLIVY. Treatment with POLIVY can cause severe low blood cell counts Rare and serious brain infections: Your doctor will monitor closely for signs and symptoms of these types of infections. Contact your doctor if you experience confusion, dizziness or loss of balance, trouble talking or walking, or vision changes Tumor lysis syndrome: Caused by the fast breakdown of cancer cells. Signs include nausea, vomiting, diarrhea, and lack of energy Potential harm to liver: Some signs include tiredness, weight loss, pain in the abdomen, dark urine, and yellowing of your skin or the white part of your eyes. You may be at higher risk if you already had liver problems or you are taking other medication Skin damage at or near the infusion site: POLIVY may leak out of the vein and into the surrounding tissue during the infusion, which can cause skin or tissue damage. Your doctor will closely monitor for signs and symptoms of skin damage during the infusion. Tell your healthcare provider immediately if you see any fluid leaking at or around the infusion site, or if you notice any burning, tingling, pain, discomfort, swelling and redness at the infusion site Side effects seen most often The most common side effects of POLIVY when used as a first treatment in DLBCL with the medicines rituximab product, cyclophosphamide, doxorubicin, and prednisone include Nerve problems in arms and legs Nausea Tiredness or lack of energy Diarrhea Constipation Hair loss Redness and sores of the lining of the mouth, lips, throat, and digestive tract POLIVY may lower your red or white blood cell counts and increase uric acid levels. The most common side effects of POLIVY when used in DLBCL after at least 2 prior therapies with other medicines, bendamustine and a rituximab product, include Low blood cell counts (platelets, red blood cells, white blood cells) Nerve problems in arms and legs Tiredness or lack of energy Diarrhea Nausea Fever Decreased appetite Infections POLIVY may not be for everyone. Talk to your doctor if you are Pregnant or think you are pregnant: Data have shown that POLIVY may harm your unborn baby Planning to become pregnant: Women should avoid getting pregnant while taking POLIVY. Women should use effective contraception during treatment and for 3 months after their last POLIVY treatment. Men taking POLIVY should use effective contraception during treatment and for 5 months after their last POLIVY treatment Breastfeeding: Women should not breastfeed while taking POLIVY and for 2 months after the last dose These may not be all the side effects. Talk to your healthcare provider for more information about the benefits and risks of POLIVY treatment. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the full Prescribing Information for additional Important Safety Information. TOP
7269 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
8Review mentions (all pages)
0External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 0 |
| /newly-diagnosed/rchp/side-effects/important-safety-information.html | 3 | 0 |
| /newly-diagnosed/rchp/taking-polivy/preparing-for-treatment.html | 3 | 0 |
| /newly-diagnosed/rchp/about-polivy/is-polivy-right-for-me.html | 1 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/newly-diagnosed/rchp/side-effects/important-safety-information.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/newly-diagnosed/rchp/taking-polivy/preparing-for-treatment.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/newly-diagnosed/rchp/about-polivy/is-polivy-right-for-me.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
BS Detector
Medical Devices, Pharma & Biotech BS: Genentech (POLIVY) (polivy.com)
https://polivy.com
📍 Industry: Medical Devices, Pharma & Biotech
25
BS / 100
A professionally sanitized pharma site with a low BS score due to strict regulatory requirements that mandate substance over marketing fluff. While the hero sections use soft power-phrases, the mandatory safety disclosures provide a level of forensic honesty rarely seen in other industries.
Info Density
Power-words vs. Substance ratio.
9
30% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
10
50% BS
Commodity Fingerprint
Detection of industry clichés/templates.
4
27% BS
Identity & Authority
Expert verifiability & Schema depth.
2
13% BS
Integrate specific clinical trial identifiers (NCT numbers) directly into the H2 headings to ground claims in verifiable research. Add Person schema for the lead researchers or medical directors to bridge the authority gap. Replace generic icons with data-driven infographics showing the efficacy of the R-CHP regimen. Ensure the ‘reviews’ flagged in metadata are linked to verified third-party patient advocacy platforms or clinical registries.
The content perfectly matches the Pharma & Biotech category, specifically focusing on oncology and therapeutics for DLBCL. The presence of extensive safety information and detailed drug combination regimens (R-CHP) confirms the classification.
“The score of 25 is primarily driven by Trust Theatre flags and mandatory repetition of content. The Information Density and Semantic Coherence pillars are exceptionally strong, as the site provides exactly what a DLBCL patient needs: technical drug data and logistical prep without significant marketing drift.”
Verified Analysis Date: May 30, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from Genentech (POLIVY), captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Genentech (POLIVY): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://polivy.com to view the most current version of its content and learn from the source what this company is about and what it offers.